Redox cycling in the metabolism of the environmental pollutant and suspected human carcinogen o-anisidine by rat and rabbit hepatic microsomes

Chemical Research in Toxicology

Volumn 21, Issue 8, 2008, Pages 1610-1621

  Naiman, Karel ^a   Dračínská, Helena ^a   Martínková, Markéta ^a   Šulc, Miroslav ^a   Dračínský, Martin ^b   Kejíková, Lucie ^a   Hodek, Petr ^a   Hudeček, Jirí ^a   Liberda, Jirí ^a   Schmeiser, Heinz H ^c   Frei, Eva ^c   Stiborová, Marie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOPHENOL; 2 ANISIDINE; 2 NITROANISOLE; CARCINOGEN; CYTOCHROME P450; HYDROXYLAMINE; N (2 METHOXYPHENYL)HYDROXYLAMINE; NITROBENZENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROSOME; NONHUMAN; OXIDATION REDUCTION REACTION; POLLUTANT; RABBIT; RAT;

ANILINE COMPOUNDS; ANIMALS; CARCINOGENS, ENVIRONMENTAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; METABOLIC DETOXICATION, DRUG; MICROSOMES, LIVER; OXIDATION-REDUCTION; RABBITS; RATS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RATTUS; RODENTIA;

EID: 51449118603     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx8001127     Document Type: Article

References (77)

1. NTP. (1978) Bioassay of o-Anisidine Hydrochloride for Possible Carcinogenicity. NTP Technical Report, Bethesda No. 89, US National Cancer Institute, Bethesda, MD.
2. International Agency for Research on Cancer (IARC) (1982) Ortho-and para-Anisidine and Their Hydrochlorides. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, No. 27, IARC, Lyon, France.
3. Garner, R. C., Martin, C. N., and Clayson, D. B. (1984) Carcinogenic Aromatic Amines and Related Compounds. In Chemical Carcinogens (Searle, C. , Ed.) 2nd ed., Vol. 1, CS Monograph 182, pp 175-302, American Chemical Society, Washington, DC.
4. Stabbert, R., Schäfer, K.-H., Biefel, C., and Rustemeier, K. (2003) Analysis of aromatic amines in cigarette smoke. Rapid Commun. Mass Spectrom. 17, 2125-2132.
5. Weiss, T., and Angerer, J. (2003) Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry. J. Chromatogr., B 778, 179-192.
6. Falter, B., Kutzer, C., and Richter, E. (1994) Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin. Invest. 72, 364-371.
7. Branner, B., Kutzer, C., Zwickenpflug, W., Scherer, G., Heller, W.-D., and Richter, E. (1998) Haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and non-smoking women. Biomarkers 3, 35-47.
8. Richter, E., Rosler, S., Scherer, G., Gostomzyk, J. G., Grubl, A., Kamer, U., and Behrendt, H. (2001) Haemoglobin adducts from aromatic amines in children in relation to area of residence and exposure to environmental tobacco smoke. Int. Arch. Occup. Environ. Health 74, 421-428.
9. Hauthal, H. G. (1993) Rosenmontag und die Folgen die Störfäalle der Hoechst AG. Nachr. Chem. Tech. Lab. 41, 440.
10. Traupe, H., Menge, G., Kandt, J., and Karmaus, W. (1997) Higher frequency of atopic dermatitis and decrease in viral warts among children exposed to chemicals liberated in a chemical accident in Frankfurt, Germany. Dermatology 195, 112-118.
11. Garner, R. C., and Nutmann, C. A. (1977) Testing of some azo dyes and their reduction products for mutahenicity using Salmonella typhimurium TA1538. Mutat. Res. 44, 2099-19.
12. Dunkel, V. C., and Simmon, V. F. (1980) Mutagenic Activity of Chemicals Previously Tested for Carcinogenicity in the National Cancer Institute Bioassay Program. In Molecular and Cellular Aspects of Carcinogenic Screening Tests, No. 27, pp 283-302, IARC, Lyon, France.
13. Ashby, J. (1995) Genetic toxicity in relation to receptor-mediated carcinogenesis. Mutat. Res. 333, 209-213.
14. Dunkel, V. C., Zeiger, E., Brusick, D., McCoy, D., McGregor, D., Mortelmans, K., Rosenkranz, H. S., and Simmon, V. F. (1985) Reproducibility of microbial mutagenicity assays. Environ. Mutagen. 7 (Suppl. 5), 24.
15. Simizu, H., and Takemura, N. (1984) Mutagenicity of Some Aniline Derivatives. In Occupational Health in the Chemical Industry, Proceedings of the Eleventh International Congress on Occupational Health in the Chemical Industry, September 26-29, 1983 (Oxford R. R., Cowel, J. W., Jamieson G. G., and Lowe E. J., Eds.) pp 497-506, Medichem, Calgary 83 Association, Calgary, Alberta, Canada.
16. Ashby, J., and Tennant, K. W. (1988) Chemical structure. Salmonella mutagenicity and extent of carcinogenicity as indicator of genotoxic carcinogenesis among 222 chemicals tested in rodents by the US NCI/NTP. Mutat. Res. 204, 17-115.
17. 32P bladder DNA adduction. Carcinogenesis 15, 2291-2296.
18. Thompson, D. C., and Eling, T. E. (1991) Reactive intermediates formed during the peroxidative oxidation of anisidine isomers. Chem. Res. Toxicol. 4, 474-481.
19. Thompson, D. C., Josephy, P. D., Chu, J. W. K., and Eling, T. E. (1992) Enhanced mutagenicity of anisidine isomers in bacterial strains containing elevated N-acetyltransferase activity. Mutat. Res. 279, 83-89.
20. Oda, Y. (2004) Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system. Mutat. Res. 554, 399-406.
21. Galloway, S. M., Armstrong, M. J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A. D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., and Margolin, B. H. (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells, evaluations of 108 chemicals. Environ. Mol. Mutagen. 10 (Suppl. 10), 1-175.
22. Wangenheim, J., and Bolcsfold, G. (1988) Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis 3, 193-205.
23. Garberg, P., Aakerblom, E. L., and Bolcsfold, G. (1988) Evaluation of a genotoxicity test measuring DNA-strand breaks in mouse lymphoma cells by alkaline anwinding and hydroxyapatite elution. Mutat. Res. 203, 155-176.
24. Brennan, R. J., and Schiestl, R. H. (1999) The aromatic amine carcinogens o-toluidine and o-anisidine induce free radicals and intrachromosomal recombination in Saccharomyces cerevisiae. Mutat. Res. 430, 37-45.
25. Sasaki, Y. F., Nishidate, E., Su, Y. Q., Matsusaka, N., Tsuda, S., Susa, N., Furukawa, Y., and Ueno, S. (1998) Organ-specific genotoxicity of the potent rodent bladder carcinogens o-anisidine and p-cresidine. Mutat. Res. 412, 155-160.
26. Glickman, B. W., Ashmed, A., Rogers, B. J., Hammer, R., Short, J. M., Tinwell, H., Lefevre, P. A., and Ashby, J. (1993) Mutational specificity of o-anisidine in the bladder of Big Blue™ mice. Environ. Mol. Mutagenesis 21 (Suppl. 22), 1.
27. Ashby, J., Lefevre, P. A., Tinwell, H., Brunborg, G., Schmezer, P., Pool-Zobel, B., Shanu-Wilson, R., Holme, J. A., Soderlund, E. J., Gulati, D., and Wojciechowski, J. P. (1991) The non-genotoxicity to rodents of the potent rodent bladder carcinogens o-anisidine and p-cresidine. Mutat. Res. 250, 115-133.
28. Morita, T., Asano, N., Awogi, T., Sasaki, Y. F., Sato, S.-I., Shimada, H., Sutou, S., Suzuki, T., Wakata, A., Sofuni, T., and Hayashi, M. (1997) Evaluation of the rodent micronucleus assays in the screening of IARC carcinogens (Groups 1, 2A and 2B). The summary report of the 6th collaborative study by CSGMT/JEMS-MMS. Mutat. Res. 389, 3-122.
29. 32P-postlabelling analysis of DNA adducts formation. Gen. Physiol. Biophys. 20, 267-279.
30. Stiborová, M., Mikšanová, M., Havlíč ek, V., Schmeiser, H. H., and Frei, E. (2002) Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA. Mutat. Res. 500, 49-66.
31. Stiborová, M., Mikšanová, M., Šulc, M., Rýdlová, H., Schmeiser, H. H., and Frei, E. (2005) Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine. Int. J. Cancer 116, 667-678.
32. Rýdlová, H., Mikšanová, M., Ryšlavá, H., and Stiborová, M. (2005) Carcinogenic pollutants o-nitroanisole and o-anisidine are substrates and inducers of cytochromes P450. Biomed. Papers 49, 441-447.
33. Smith, J. N., and Williams, R. T. (1949) Studies in detoxication. 24. The metabolism of p-phenetidine (p-ethoxyaniline) with some observations on the anisidines (methoxyanilines). Biochem. J. 44, 250-255.
34. Schmidt, H. L., Möller, M. R., and Weber, N. (1973) Influence of substrates on the microsomal dealkylation of aromatic N-, O- and S-alkyl compounds. Biochem. Pharmacol. 22, 2989-2996.
35. Guengerich, F. P. (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem.-Biol. Interact. 106, 161-182.
36. 32P-postlabelling methods. A review. Collect. Czech. Chem. Commun. 69, 477-498.
37. Seidenfaden, W. (1971) Methoden der Organischen Chemie (Houben-Weyl), p 1058,Band X/1 Georg Thieme Verlag, Stuttgart, Germany.
38. Olah, G. A., Wu, A., Farooq, O., and Prakash, G. K. S. (1990) Synthetic methods and reactions. 146. Olefins from crowded carbonyl-compounds with tert-butyllithium (tert-butylmagnesium chloride) thionyl chloride - study of carbocationic reaction intermediates and rearrangement cleavage under stable ion conditions using C-13 NMR-spectroscopy. J. Org. Chem. 55, 1792-1796.
39. Balaban, A. T., Garfield, R. E., Lesko, M. J., and Seitz, W. A. (1998) Synthesis and spectral data of some new N-nitroso-N-phenylhydroxylamine (Cupferron) derivatives. Org. Prep. Proced. Int. 30, 439-446.
40. Stiborová, M., Asfaw, B., Anzenbacher, P., Lešetický , L., and Hodek, P. (1988) The first identification of the benzenediazonium ion formation from a non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene (Sudan I) by microsomes of rat livers. Cancer Lett 40, 319-326.
41. Stiborová, M., Asfaw, B., Frei, E., Schmeiser, H. H., and Wiessler, M. (1995) Benzenediazonium ion derived from Sudan I forms an 8-(phenylazo)guanine adduct. Chem. Res. Toxicol. 8, 489-498.
42. Hodek, P., Jansčák, P., Anzenbacher, P., Burkhard., J., Jankù, J., and Vodička, L. (1988) Metabolism of diamantane by rat-liver microsomalcytochromes P-450. Xenobiotica 18, 1109-1118.
43. Gut, I, Nedelcheva, V., Souček, P., Stopka, P., Vodička, P., Gelboin, H. V., and Ingelman-Sundberg, M. (1996) The role of CYP2E1 and 2B1 in metabolic activation of benzene derivatives. Arch. Toxicol. 71, 45-56.
44. Borek-Dohalská, L., Hodek, P., Šulc, M., and Stiborová, M. (2001) α-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal P4503A6. Chem.-Biol. Interact. 138, 85-106.
45. Yang, C. S., Tu, Y. Y., Koop, D. R., and Coon, M. J. (1985) Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes. Cancer Res. 45, 1140-1145.
46. Wiechelman, K. J., Braun, R. D., and Fitzpatrick, J. D. (1988) Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation. Anal. Biochem. 175, 231-237.
47. Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378.
48. Sottocasa, G. L., Kuylenstierna, I., Ernster, I., and Bergstrand, A. (1967) An electron transport system associated with the outer membrane of liver mitochondria. J. Cell Biol. 32, 415-438.
49. Haugen, D. A., and Coon, M. J. (1976) Properties of electrophoretically homogeneous phenobarbital-inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem. 251, 7929-7939.
50. Stiborová, M., Borek-Dohalská, L., Hodek, P., Mráz, J, and Frei, E. (2002) New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen. Arch. Biochem. Biophys. 403, 41-49.
51. Saito, T., and Strobel, H. W. (1981) Purification to homogeneity and characterization of a form of cytochrome P-450 with high specificity for benzo[a]pyrene from β-naphthoflavone-pretreated rat liver microsomes. J. Biol. Chem. 256, 984-988.
52. Yasukochi, Y., Peterson, J. A., and Masters, B. (1979) NADPH-cytochrome c (P450) reductase: spectrophotometric and stopped flow kinetic studies on the formation of reduced fiavoprotein intermediates. J. Biol. Chem. 254, 7097-7104.
53. 5. Methods Enzymol. 52, 97-101.
54. Burke, M., D., Thompsom, S., Elcombe, O. R., Halpert, J., Haaparanta, T., and Mayer, R. T. (1985) Ethoxy-, penthoxy- and benzyloxyphenazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34, 3337-3345.
55. 5 or heme oxygenase. J. Biol. Chem. 276, 30885-30891.
56. Chauret, N., Gauther, A., and Nicoll-Griffith, D. A. (1998) Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug. Metab. Dispos. 26, 1-4.
57. Lubet, R. A., Mayer, R. T., Cameron, J. W., Nims, R. W., Burke, M. D., Wolff, T., and Guengerich, F. P. (1985) Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238, 43-48.
58. Guengerich, F. P. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem. Res. Toxicol. 4, 391-407.
59. Borek-Dohalská, L., Hodek, P., and Stiborová, M. (1999) New selective inhibitors of cytochrome P450 2B4 and an activator of cytochrome P450 3A6 in rabbit liver microsomes. Collect. Czech. Chem. Commun. 65, 122-132.
60. Stiborová, M., Mikšanová, M., Smrček, S., Bieler, C. A., Breuer, A, Klokow, K. A., Schmeiser, H. H., and Frei, E. (2004) Identification of a genotoxic mechanism for 2-nitroanisole carcinogenicity and of its carcinogenic potential for humans. Carcinogenesis 25, 833-840.
61. Mikšanová, M., Novák, P., Frei, E., and Stiborová, M. (2004) Metabolism of carcinogenic 2-nitroanisole by rat, rabbit, porcine and human hepatic cytosol. Collect. Czech. Chem. Commun. 69, 589-602.
62. Müller, E., and Kreutzmann, W. (1932) Stereomerie von Azoxybenzolen II. Justus Liebigs Annalen der Chemie 495, 132-143.
63. Kohnstam, G., Petch, W. A., and Williams, D. (1984) Kinetic substituent and isotope effects in the acid-catalysed rearrangement of N-phenylhydroxylamines. Are nitrenium ions involved? J. Chem. Soc., Perkin Trans. II 423-427.
64. Jurlina, J. L., Lindsay, A., Packer, J. E., Baguley, B. C., and Denny, W. A. (1987) Redox chemistry of the 9-anilinoacridine class of antitumor agents. J. Med. Chem. 30, 473-480.
65. Kim, D., Kadlubar, F. F., Teitel, C. H., and Guengerich, F. P. (2004) Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines. Chem. Res. Toxicol. 17, 529-536.
66. Kirchner, G., and Bayer, U. (1992) Genotoxic activity of the aminophenols as evidenced by the induction of sister chromatid exchanges. Hum. Toxicol. 1, 387-392.
67. Brennan, R. J., and Schiestl, R. H. (1997) Aniline and its metabolite generate free radicals in yeast. Mutagenesis 12, 215-220.
68. Okhuma, Y., and Kawanishi, S. (2001) Oxidative DNA damage induced by a metabolite of carcinogenic o-anisidine: enhancement of DNA damage and alteration in its sequence specificity by superoxide dismutase. Arch. Biochem. Biophys. 389, 49-56.
69. Rehn, L. (1895) Blasengeschwülste bei Fuchsin-arbeitern. Arch. Klin. Chir. 50, 588-600.
70. Beland, F. A., Fullerton, N. F., and Heflich, R. H. (1984) Rapid isolation, hydrolysis and chromatography of formaldehyde-modified DNA. J. Chromatogr. 308, 121-131.
71. Huang, H., and Hopkins, P. B. (1993) DNA interstrand cross-linking by formaldehyde: nucleotide sequence preference and covalent structure of the predominant cross-link formed in synthetic olionucleotides. J. Am. Chem. Soc. 115, 9402-9408.
72. Cheng, G., Shi, Y., Sturla, S., Jalas, J., McIntee, E. J., Villalta, P. W., Wang, M., and Hecht, S. S. (2003) Reactions of formaldehyde plus acetaldehyde with deoxyguanosine and DNA: Formation of cyclic deoxyguanosine adducts and formaldehyde cross-links. Chem. Res. Toxicol. 16, 145-152.
73. International Agency for Research on Cancer (2006) Formaldehyde, 2-Butoxyethanol and 1-terc-Butoxypropan-2-ol. In IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 88, pp 39-325, IARC, Lyon, France.
74. U.S. Department of Health and Human Services (2004) 11th Report on Carcinogens, U.S. Government Printing Office, Washington, DC.
75. Sprattt, T., Peterson, L.A A., Confer, W. L., and Hecht, S. S. (1990) Solvolysis of model compounds for α-hydroxylation of N- nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-nutanone. Evidence for a cyclic oxonium ion intermediate in the alkylation of nucleotides. Chem. Res. Toxicol. 3, 350-356.
76. Dhareshwar, S. S., and Stella, V. J. (2008) Your prodrug releases formaldehyde: Should you be concerned? No! J. Pharm. Sci. [Online early access], DOI: 10.1002/jps.21319, published online, Feb 20, 2008.
77. Imaoka, S., Osada, M., Minamiyama, Y., Yukimura, T., Toyokuni, S., Takemura, S., Hiroi, T., and Funae, Y. (2004) Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett. 203, 117-125.